Australian research unlocks new path for cancer immunotherapy

Australian-led research is unlocking new ways for immunotherapy to better target cancer.

LivaNova warns cybersecurity incident disrupts systems, takes steps to limit impact

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: LivaNova disclosed that a cybersecurity

November 27, 2023

Mind-altering ketamine becomes latest pain treatment, despite little research or regulation

WASHINGTON (AP) — As U.S. doctors scale back their use of opioid painkillers, a new option for hard-to-treat pain is taking root: ketamine, the decades-old surgical

November 7, 2023

AbbVie, Genmab tout Epkinly combos in earlier lines of non-Hodgkin lymphoma

SAN DIEGO — AbbVie and Genmab are building the case for their bispecific Epkinly in earlier lines of treatment, presenting longer-term combination data in two

December 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.